Xtandi 40 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DX25F6ABK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $59,225
Award facts
- Contract value 100% obligated
- $59,224.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $59,224.82 on July 17, 2025, for the supply of Xtandi 40 mg tablets (120 count) to support federal pharmaceutical needs. The award was issued without a set-aside designation and carries an ultimate completion date of July 18, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency under the SPE2DB program, a $499.99 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure recurring contracts with the Defense Logistics Agency. The company's contract portfolio encompasses an extensive array of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables. Xtandi, an oncology treatment medication, aligns with the company's demonstrated capability in delivering specialized pharmaceutical products to Department of Defense healthcare sites. The completion timeline of one day reflects the expedited nature of this specific delivery order against the broader IDC framework.
Quick answers
Who was awarded contract SPE2DX25F6ABK?
SPE2DX25F6ABK was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 17, 2025.
How much is contract SPE2DX25F6ABK worth?
The government has obligated $59,225 on SPE2DX25F6ABK.
Is contract SPE2DX25F6ABK an order under another contract?
Yes. SPE2DX25F6ABK is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ABK competed?
The extent of competition for SPE2DX25F6ABK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award